pharma · Scabies · Bioequivalence trial in healthy volunteers
Alphapharm
Alphapharm Pty Ltd
Alphapharm Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Scabies, Bioequivalence trial in healthy volunteers, moderate to severely inflamed candidiasis of the skin, Mild to mod
Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU HQ
1982 Founded
187 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU
- Founded
- 1982
- Employees
- 187
- Programs
- 30
- Drugs
- 235
- Patents
- 12
Debio 0123-106
Phase 1 · small molecule · Advanced solid tumors with CCNE1 amplification or deleterious mutations in FBXW7 or other proprietary gene
Debio 0123-106 for Advanced solid tumors with CCNE1 amplification or deleterious mutations in FBXW7 or other proprietary gene is a Phase 1 program (small_molecule) at Alphapharm Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code Debio 0123-106
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Alphapharm Pty Ltd
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Advanced solid tumors with CCNE1 amplification or deleterious mutations in FBXW7 or other proprietary gene
- Status
- active
- Trials
- 1